Evidence map›Paper›PMID 40770831›Full record

ArticleClinical and translational medicine2025

SFPQ subcellular mislocalisation entails altered cancer cell function.

Libang Yang, Adam Gilbertsen, Blake Jacobson, Robert Kratzke, Yingming Li, Bo Sun, Sabine Karam, Scott M Dehm, Craig A Henke

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Libang YangDepartment of Medicine, School of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.ORCID https://orcid.org/0000-0002-9318-6320
Adam GilbertsenDepartment of Medicine, School of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Blake JacobsonDepartment of Hematology, Oncology and Transplantation, School of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Robert KratzkeDepartment of Hematology, Oncology and Transplantation, School of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Yingming LiMasonic Cancer Center, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Bo SunDivision of Gastro, Hepatology, Nutrition, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Sabine KaramDivision of Nephrology, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Scott M DehmMasonic Cancer Center, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
Craig A HenkeDepartment of Medicine, School of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.

Funding

AR Gene Rearrangements and AR Signaling in Prostate CancerR01CA174777 · NCI · UNIVERSITY OF MINNESOTA · PI Scott M. Dehm · 2013 to 2026
$4.9M
Integrin-Matrix Regulation of IPF Fibroblast PhenotypeR01HL125227 · NHLBI · UNIVERSITY OF MINNESOTA · PI HENKE, CRAIG A · 2015 to 2018
$1.8M
mRNA Polyadenylation in Prostate CancerR01CA244599 · NCI · UNIVERSITY OF MINNESOTA · PI DEHM, SCOTT M. · 2020 to 2020
$386k
NCI NIH HHS R01 CA174777NCI NIH HHS R01 CA244599NIH HHS R01 HL125227
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40770831
PMCPMC12328246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.